Concepedia

Publication | Open Access

Sirolimus-based immunosuppression improves outcomes in liver transplantation recipients with hepatocellular carcinoma beyond the Hangzhou criteria

17

Citations

16

References

2020

Year

Abstract

SRL can improve survival outcomes in LT patients with HCC exceeding the Hangzhou criteria.

References

YearCitations

Page 1